menu
    • menu

    Company profile for Cheplapharm Arzneimittel Gmbh

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CHEPLAPHARM is a European pharmaceutical company headquartered in Germany that sells branded products worldwide. With an internationally oriented buy-and-build strategy, the family-owned company generates increasing growth rates every year. The close cooperation with our cooperation partners and subsidiaries enables CHEPLAPHARM to successfully implement the corporate strategy .

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cheplapharm Arzneimittel GmbhGermany Flag
    Country
    Country
    Germany
    Address
    Address
    BAHNHOFSTR. 1A
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cheplapharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cheplapharm Digitizes Supply Chain with TraceLink MINT
    Cheplapharm Digitizes Supply Chain with TraceLink MINT

    14 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cheplapharm-to-accelerate-global-supply-chain-digitalization-with-tracelink-mint-302772406.html

    PR NEWSWIRE
    14 May 2026
    Share Share
    CHEPLAPHARM with stable business in the first half of 2025
    CHEPLAPHARM with stable business in the first half of 2025

    27 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-27/cheplapharm-with-stable-business-in-the-first-half-of-2025

    PHARMAWEB
    27 Aug 2025
    Share Share
    Cheplapharma expands Management with Tamás as VP Commercial
    Cheplapharma expands Management with Tamás as VP Commercial

    02 Jan 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-01-02/cheplapharm-expands-management-with-tam%C3%A1s-sz%C3%B3ga-as-vp-commercial

    PHARMAWEB
    02 Jan 2025
    Share Share
    Cheplapharm acquires Gemzar from Lilly
    Cheplapharm acquires Gemzar from Lilly

    16 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-16/cheplapharm-acquires-gemzar-from-lilly

    PHARMAWEB
    16 Dec 2024
    Share Share
    Cheplapharm places notes in a volume of €750m in challenging market environment
    Cheplapharm places notes in a volume of €750m in challenging market environment

    28 Apr 2023

    // PRESS RELEASE

    https://www.cheplapharm.com/en/press-news/news-detail/cheplapharm-places-notes-in-a-volume-of-eur750m-in-challenging-market-environment/

    PRESS RELEASE
    28 Apr 2023
    Share Share
    Cheplapharm selects Generis’ CARA platform to unify clinical processes
    Cheplapharm selects Generis’ CARA platform to unify clinical processes

    20 Jan 2023

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/cheplapharm-selects-generis-cara-life-sciences-platform-to-unify-their-clinical-processes-13626

    INDIANPHARMAPOST
    20 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search